SNOA Research and Charts

SNOA - Sonoma Pharmaceuticals Inc (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2024-09-23 (Delayed quote data 2025-01-06)

Last 2.69	Change ⇑ +0.05 (+1.89%)	Volume 56,365
	Open 2.66	High 2.76	Low 2.63

8EMA (Daily) 2.69	40EMA (Daily) 2.72	50EMA (Daily) 2.70	STO (Daily) 54.808	MACD Hist (Daily) 0.002
8EMA (Weekly) 2.706	40EMA (Weekly) 1.94	50EMA (Weekly) 1.77	STO (Weekly) 15.457	MACD Hist (Weekly) -0.182


Company Profile
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.